Similar articles for PMID: 10984541

Year	Number of Results
1998	1
1999	1
2000	1
2001	2
2002	6
2003	7
2004	6
2005	10
2006	4
2007	9
2008	7
2009	8
2010	9
2011	8
2012	3
2013	6
2014	7
2015	4
2016	3
2017	9
2018	4
2019	1
2020	1
2021	1
2022	1
2024	0

1

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. Brines ML, et al. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10526-31. doi: 10.1073/pnas.97.19.10526. Proc Natl Acad Sci U S A. 2000. PMID: 10984541 Free PMC article.

2

Effects of epoetin alfa on the central nervous system.

Cerami A, Brines ML, Ghezzi P, Cerami CJ. Cerami A, et al. Semin Oncol. 2001 Apr;28(2 Suppl 8):66-70. doi: 10.1016/s0093-7754(01)90216-7. Semin Oncol. 2001. PMID: 11395856 Review.

3

Neuroprotective properties of epoetin alfa.

Cerami A, Brines M, Ghezzi P, Cerami C, Itri LM. Cerami A, et al. Nephrol Dial Transplant. 2002;17 Suppl 1:8-12. doi: 10.1093/ndt/17.suppl_1.8. Nephrol Dial Transplant. 2002. PMID: 11812906 Review.

4

Derivatives of erythropoietin that are tissue protective but not erythropoietic.

Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M. Leist M, et al. Science. 2004 Jul 9;305(5681):239-42. doi: 10.1126/science.1098313. Science. 2004. PMID: 15247477

5

Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.

Hellewell SC, Yan EB, Alwis DS, Bye N, Morganti-Kossmann MC. Hellewell SC, et al. J Neuroinflammation. 2013 Dec 18;10:156. doi: 10.1186/1742-2094-10-156. J Neuroinflammation. 2013. PMID: 24344874 Free PMC article.

6

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.

Yoo SJ, Cho B, Lee D, Son G, Lee YB, Soo Han H, Kim E, Moon C, Moon C. Yoo SJ, et al. Cell Death Dis. 2017 Aug 17;8(8):e3003. doi: 10.1038/cddis.2017.381. Cell Death Dis. 2017. PMID: 28817120 Free PMC article.

7

Recombinant human erythropoietin for neuroprotection: what is the evidence?

Eid T, Brines M. Eid T, et al. Clin Breast Cancer. 2002 Dec;3 Suppl 3:S109-15. doi: 10.3816/cbc.2002.s.021. Clin Breast Cancer. 2002. PMID: 12533271 Review.

8

Neuroprotection by erythropoietin administration after experimental traumatic brain injury.

Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, Iacopino DG. Grasso G, et al. Brain Res. 2007 Nov 28;1182:99-105. doi: 10.1016/j.brainres.2007.08.078. Epub 2007 Sep 14. Brain Res. 2007. PMID: 17935704

9

Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.

Juul S. Juul S. Acta Paediatr Suppl. 2002;91(438):36-42. doi: 10.1111/j.1651-2227.2002.tb02904.x. Acta Paediatr Suppl. 2002. PMID: 12477263 Review.

10

Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.

Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, Chechushkov AV, Voynova IV, Elizarova AY, Kolmakov NN, Bass MG, Semak IV, Budevich AI, Kozhin PM, Zenkov NK, Klimenko VM, Kirik OV, Korzhevskii DE, Menshchikova EB, Vasilyev VB. Zakharova ET, et al. Biometals. 2018 Jun;31(3):425-443. doi: 10.1007/s10534-018-0111-9. Epub 2018 May 10. Biometals. 2018. PMID: 29748743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year